Quick Answer
Astrana Health, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $3.18 billion for the year ending 2025.
- Astrana Health, Inc. showed an increase of +56.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Astrana Health, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $122.67 million | Q3 2018: $166.73 million | Q1 2019: $95.76 million | Q2 2019: $130.05 million | Q3 2019: $156.06 million | Q4 2019: $178.75 million | Q1 2020: $165.11 million | Q2 2020: $165.17 million | Q3 2020: $180.12 million | Q4 2020: $176.78 million | Q1 2021: $176.06 million | Q2 2021: $175.64 million | Q3 2021: $227.12 million | Q1 2022: $263.26 million | Q2 2022: $269.70 million | Q3 2022: $317.00 million | Q1 2023: $337.24 million | Q2 2023: $348.21 million | Q3 2023: $348.17 million | Q1 2024: $404.36 million | Q2 2024: $486.27 million | Q3 2024: $478.71 million | Q1 2025: $620.39 million | Q2 2025: $654.81 million | Q3 2025: $956.05 million.
- Over the full 9 years of available data (2017 to 2025), Astrana Health, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 792.9%.
- Historical annual values: Fiscal year 2025: $3.18 billion | Fiscal year 2024: $2.03 billion | Fiscal year 2023: $1.39 billion | Fiscal year 2022: $1.14 billion | Fiscal year 2021: $773.92 million | Fiscal year 2020: $687.18 million | Fiscal year 2019: $560.62 million | Fiscal year 2018: $519.91 million | Fiscal year 2017: $356.36 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: